Preliminary > Science and Technology > Biotechnology > COVID 19
Why in news? India’s first indigenous mRNA vaccine for the Omicron variant, GEMCOVAC-OM has been approved under ...
Preliminary > Science and Technology > Biotechnology > COVID 19
Why in news? Bharat Biotech International Limited announced that iNCOVACC, has received approval from the Drugs Co...
Preliminary > Science and Technology > Biotechnology > COVID 19
Why in news? The Pune-based Gennova Biopharmaceuticals is expected to roll out India’s first home-grown mRNA...
Preliminary > Science and Technology > Miscellaneous > COVID 19
Why in news? India gave emergency-use authorisation to two more vaccines- Corbevax and Covovax. About Corbeva...
Preliminary > Science and Technology > Miscellaneous > COVID 19
Why in news? Researchers have developed an experimental chewing gum that traps SARS-CoV-2 viral particles, the cor...
Preliminary > Disaster Management > Disasters > COVID 19
Why in news? An expert panel of India's Central Drug Authority, which recently reviewed Serum Institute's ...
Preliminary > Disaster Management > Disasters > COVID 19
Why in news? The World Health Organisation (WHO) designated SARS-CoV-2 variant B.1.1529 (named as Omicron) as a &l...
Preliminary > Science and Technology > Miscellaneous > COVID 19
Why in news India’s first indigenous COVID-19 vaccine, Bharat Biotech’s Covaxin, was granted Emergency...
Preliminary > Social Justice > Health > COVID 19
Why in news? The decline in daily new infections across India has prompted INSACOG, the consortium of labs focusse...
Preliminary > Disaster Management > Miscellaneous > COVID 19
Why in news? Prime minister’s Citizen Assistance and Relief in Emergency Situation Fund (PM-CARES Fund), a chari...